SlideShare a Scribd company logo
Presented By-
ROHIT
R.K.S.D college of
pharmacy, Kaithal (Hry)
M.Pharma 1st year
(Pharmaceutics)
It is defined for a paper submission as a
set of pages, numbered sequentially and
divided from other documents by a tab.
A document can be equated to a file for
an electronic submission.
CTD WAS OFFICIALLY SIGNED OFF IN
NOVEMBER 2000, AT5TH ICH CONFERENCE,
SAN DIEGO,CALIFORNIA.
CTD eCTD
The objective is to increase international
harmonization of technical requirements to ensure
that safe, effective, and high quality medicines are
developed and registered in the most efficient and
cost‐effective manner.
Activities have been undertaken to promote public
health, prevent unnecessary duplication.
What is ICH ?
•The complete name of ICH is the "International Conference
on Harmonization of Technical Requirements for Registration
of Pharmaceuticals for Human Use".
•The purpose is to make recommendations on ways to achieve
greater harmonization in the interpretation and application of
technical guidelines and requirements for product registration
in order to reduce or prevent the need to duplicate the testing
carried out during the research and development of new
medicines.
• This unique project brings together the participants in the
three regions to discuss scientific and technical aspects of product
registration
The focus of the is to provide a common format for the
preparation of a well structured submission according
to the modular framework described in the ICH
guidelines of the Common Technical Document for
Registration for Human Use (ICH Topic M4).
The CTD guidance indicates where and how
available information is to be presented.
The CTD is not intended to indicate what studies are
actually required (Authorities can ask for specific types
of data).
CTD is a joint effort of 3 Regulatory Agencies-
 European Medicines Agency (EMEA, Europe)
 Food and Drug Administration (FDA, USA) and
 Ministry of Health, Labour and Welfare (MHLW,
Japan).
CTD is maintained by ICH through Expert working
group (EWG). It has been adopted by several
other countries including Canada and Switzerland
These different steps are called STATUS of that
Guideline-
STATUS FUNCTIONALITY
STEP 1 Development of Consensus
STEP 2 Text released for Consultation
STEP 3 Consultation outside ICH
STEP 4 ICH Guidelines Finalized
STEP 5 Implementation
Avoid generating and compiling different registration
dossiers Common format will significantly reduce the
time and resources Facilitates simultaneous submission
in three regions Facilitates exchange of information
among regulatory authorities Faster availability of new
medicines.
The CTD is organized into FIVE modules:
 Module 1: Regional Administrative Information.
 Module 2: Introduction, Quality Overall Summary,
Nonclinical Overview, Clinical Overview, Nonclinical
Written and Tabulated Summaries, Clinical Summary
 Module 3: Quality
 Module 4: Nonclinical Study Reports
 Module 5: Clinical Study Reports.
The Common Technical Document is
organized into five modules. Module 1 is
region specific and modules 2, 3, 4 and 5 are
intended to be common for all regions.
1. ADMINISTRATIVE
1. FDA form 356h
2. Cover letter
3. Patent information
4. Department Certification
5. Field copy certification
6. User Fee cover sheet
7. Financial disclosure information
1. CTD Table of content
2. CTD Introduction
3. Quality Control Summary
4. Non-Clinical Overview
5. Clinical Overview
6. Non Clinical Summary
7. Clinical Summary
CTD AND ECTD
CTD AND ECTD
CTD AND ECTD
CTD AND ECTD
CTD AND ECTD
CTD AND ECTD
• The eCTD is the electronic equivalent to the CTD.
Why electronic?
–Improve the submission and review process
–Increase accuracy of the submission
–Decrease total costs
•This specification has been developed by the ICH
M2 Expert Working group and maintained by the
eCTD Implementation Working group in accordance
with the ICH Process.
eCTD Changes
•XML based eCTD backbone replaces PDF Tables of Content
(index xml file). The purpose of this file is two‐fold:
• Manage meta‐data for the entire submission
•Constitute a comprehensive table of contents and provide
corresponding navigation aid
•Increase document granularity in accordance with ICH eCTD
agreements.
• Life Cycle Management:
–Composed at least of an initial submission
–Incremental updates
–Only what was changed needs to be re‐submitted
eCTD Specification v 3.2
eCTD is a message specification for the transfer
of files and metadata from industry to regulatory.
The eCTD Specification version 3.2 describes
many optional folders and file names.
CTD AND ECTD
eCTD SUBMISSION CHECKLIST-
 eCTD Software
 Software training and support from the supplier
 Compiling and eCTD
 eCTD hyper linking
 QC of eCTD
 Submit eCTD on CD/DVD or Use electronic gateway
eCTD Implementation-
eCTD is implemented in 2009
•ICH‐eCTD is an internationally driven standard designed to
reduce cost in the administration, assessment and archiving of
applications for marketing authorization of medicinal products
for human use, to reduce the use of paper and streamline the
assessment process making the system more efficient.
•Unlike CTD the eCTD is not mandatory in Europe (highly
recommended).
•NCAs are progressively adapting their infrastructure,
processes and legislation to be able to receive and handle
paperless applications for marketing authorization by 2009.
Benefits of eCTD
• Improved handling and archiving of submissions
• Better information management Support of Life Cycle
Management
• Immediate Access to complete and up‐to‐date information
•Search functionality for assessors and increased tracking
ability
• Facilitated evaluation and better visibility of the process
•Reduced workload and reuse of information for assessment
reports
• Controlled communication with external experts
• Better use of resources
• Simplified business process
• Better communication with industry
SFDA Plan for Submission-
• Application form should be submitted online
•SFDA will require the product file in both CTD(Hardcopy)
and eCTD (Softcopy) format
•Product file registration should follow the current
requirements, but in CTD format
SFDA Prospective for Submission
• Learning process
• Step by step implementation
• Review of the business process
• Build a workflow system
• Pilot phase
• Smooth transition
CTD AND ECTD

More Related Content

PPTX
Ctd and e ctd
PPTX
CTD & eCTD
PPTX
Basic concepts about regulatory affairs
PPT
CTD and ECTD Document
PPTX
CTD and E-CTD Regulatory Affairs
PPT
The Electronic Regulatory Submission
PDF
New drug approval ppt
PPTX
ANDA filing
Ctd and e ctd
CTD & eCTD
Basic concepts about regulatory affairs
CTD and ECTD Document
CTD and E-CTD Regulatory Affairs
The Electronic Regulatory Submission
New drug approval ppt
ANDA filing

What's hot (20)

PPTX
Drug master file
PPTX
Investigation of medicinal product dossier (IMPD)
PPTX
PPTX
cmc [ chemistry manufacturing control ]
PPTX
DMF Drug Master File
PDF
CTD & ECTD
PDF
Electronic Common Technical Document (eCTD)
PPTX
CTD and eCTD Seminar.pptx
PPTX
CTD and eCTD Format
PPTX
Dossier Preparation/ CTD (Common Technical Document)
PPTX
Drug Master File (Regulatory Affairs) PPT
PPTX
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
PPTX
Global Subbmission of IND, NDA, ANDA
PPTX
Documentation in Pharmaceutical Industry
PPTX
Regulatory requirements for api registration
PPTX
Drug Master File submissions
PPTX
CTD and eCTD
PPTX
HATCH -WAXMAN ACT
Drug master file
Investigation of medicinal product dossier (IMPD)
cmc [ chemistry manufacturing control ]
DMF Drug Master File
CTD & ECTD
Electronic Common Technical Document (eCTD)
CTD and eCTD Seminar.pptx
CTD and eCTD Format
Dossier Preparation/ CTD (Common Technical Document)
Drug Master File (Regulatory Affairs) PPT
Regulatory Requirement for the Product Approval of Biologics Ppt.pptx
Global Subbmission of IND, NDA, ANDA
Documentation in Pharmaceutical Industry
Regulatory requirements for api registration
Drug Master File submissions
CTD and eCTD
HATCH -WAXMAN ACT
Ad

Similar to CTD AND ECTD (20)

PPTX
CTD and eCTD
PPTX
CTD & E-CTD
PPTX
CTD & ectd.pptx
PDF
CTD and eCTD_ bhakti.pdf
PDF
Common Technical Document
PPTX
Ctd & ectd
PPTX
Ctd and ectd m pharmacy notes scop satara
PPTX
CTD AND ECTD IN QUALITY ASSURANCE BY INTHIYAZ RIPER
PPTX
PPTX
CTD structure
PPTX
Presentation on the Common Technical Document [CTD] and Electronic Common Te...
PPTX
COMMON TECHNICAL DOCUMENT & ELECTRONIC COMMON TECHNICAL DOCUMENT.pptx
PPTX
CTD (common technical document)
PPTX
Regulatory Affairs CTD & eCTD Detailed overview .pptx
PPTX
ECTD BY NITESH
PPTX
121725101010-CTDandeCTD.pptx
PPTX
CTD & ECTD BY kajal prasad (2).pptx
PPT
Common technical document
PPTX
Common Technical Document CTD,M pharm@ 1st year
PDF
CTD AND ECTD common tecnical document and electroniic common technical document
CTD and eCTD
CTD & E-CTD
CTD & ectd.pptx
CTD and eCTD_ bhakti.pdf
Common Technical Document
Ctd & ectd
Ctd and ectd m pharmacy notes scop satara
CTD AND ECTD IN QUALITY ASSURANCE BY INTHIYAZ RIPER
CTD structure
Presentation on the Common Technical Document [CTD] and Electronic Common Te...
COMMON TECHNICAL DOCUMENT & ELECTRONIC COMMON TECHNICAL DOCUMENT.pptx
CTD (common technical document)
Regulatory Affairs CTD & eCTD Detailed overview .pptx
ECTD BY NITESH
121725101010-CTDandeCTD.pptx
CTD & ECTD BY kajal prasad (2).pptx
Common technical document
Common Technical Document CTD,M pharm@ 1st year
CTD AND ECTD common tecnical document and electroniic common technical document
Ad

More from ROHIT (20)

PPTX
Targeted drug delivery system for particular site
PPTX
NASAL_AND_PULMONARY_DRUG_DELIVERY SYSTEM
PPTX
TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
PPTX
Gastrorentative drug delivery systems GRDDS
PPTX
NIOSOMES: AN EMERGING TOOL FOR ANTI-AGING COSMECEUTICALS
PPTX
Life skills ppt
PPTX
Plant tissue culture & its application (PTC)
PPTX
Nutraceuticals (Nutrition + Pharmaceutical)
PPTX
Scale up post approval changes
PPTX
Application of UV-Visible spectroscopy
PPTX
Fluorimetry/ Fluoroscences
PPTX
UV- Visible Spectroscopy
PPTX
Pilot plant Scale up techniques
PPTX
colon targetting
PPTX
Niosomes (TARGETTEDDRUG DELIVERY SYSTEM)
PPTX
Nanoparticles AS AN TARGETTED DRUG DELIVERY SYSTEM
PPTX
Microspheres USED AS DRUG DELIVERY SYSTEM
PPTX
APTAMERS
PPTX
LIPOSOMES USED AS AN DRUG DELIVERY SYSTEMS
PPTX
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
Targeted drug delivery system for particular site
NASAL_AND_PULMONARY_DRUG_DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
Gastrorentative drug delivery systems GRDDS
NIOSOMES: AN EMERGING TOOL FOR ANTI-AGING COSMECEUTICALS
Life skills ppt
Plant tissue culture & its application (PTC)
Nutraceuticals (Nutrition + Pharmaceutical)
Scale up post approval changes
Application of UV-Visible spectroscopy
Fluorimetry/ Fluoroscences
UV- Visible Spectroscopy
Pilot plant Scale up techniques
colon targetting
Niosomes (TARGETTEDDRUG DELIVERY SYSTEM)
Nanoparticles AS AN TARGETTED DRUG DELIVERY SYSTEM
Microspheres USED AS DRUG DELIVERY SYSTEM
APTAMERS
LIPOSOMES USED AS AN DRUG DELIVERY SYSTEMS
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)

Recently uploaded (20)

PDF
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
PDF
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
PDF
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
PPTX
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
PDF
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
PPTX
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
PDF
Classroom Observation Tools for Teachers
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PDF
Module 4: Burden of Disease Tutorial Slides S2 2025
PDF
Abdominal Access Techniques with Prof. Dr. R K Mishra
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
PDF
Microbial disease of the cardiovascular and lymphatic systems
PDF
01-Introduction-to-Information-Management.pdf
PPTX
Cell Types and Its function , kingdom of life
PDF
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
PDF
O7-L3 Supply Chain Operations - ICLT Program
PPTX
Institutional Correction lecture only . . .
PDF
O5-L3 Freight Transport Ops (International) V1.pdf
PPTX
Pharmacology of Heart Failure /Pharmacotherapy of CHF
PPTX
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
Chapter 2 Heredity, Prenatal Development, and Birth.pdf
3rd Neelam Sanjeevareddy Memorial Lecture.pdf
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
BOWEL ELIMINATION FACTORS AFFECTING AND TYPES
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
Introduction_to_Human_Anatomy_and_Physiology_for_B.Pharm.pptx
Classroom Observation Tools for Teachers
STATICS OF THE RIGID BODIES Hibbelers.pdf
Module 4: Burden of Disease Tutorial Slides S2 2025
Abdominal Access Techniques with Prof. Dr. R K Mishra
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
Microbial disease of the cardiovascular and lymphatic systems
01-Introduction-to-Information-Management.pdf
Cell Types and Its function , kingdom of life
Physiotherapy_for_Respiratory_and_Cardiac_Problems WEBBER.pdf
O7-L3 Supply Chain Operations - ICLT Program
Institutional Correction lecture only . . .
O5-L3 Freight Transport Ops (International) V1.pdf
Pharmacology of Heart Failure /Pharmacotherapy of CHF
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...

CTD AND ECTD

  • 1. Presented By- ROHIT R.K.S.D college of pharmacy, Kaithal (Hry) M.Pharma 1st year (Pharmaceutics)
  • 2. It is defined for a paper submission as a set of pages, numbered sequentially and divided from other documents by a tab. A document can be equated to a file for an electronic submission.
  • 3. CTD WAS OFFICIALLY SIGNED OFF IN NOVEMBER 2000, AT5TH ICH CONFERENCE, SAN DIEGO,CALIFORNIA. CTD eCTD
  • 4. The objective is to increase international harmonization of technical requirements to ensure that safe, effective, and high quality medicines are developed and registered in the most efficient and cost‐effective manner. Activities have been undertaken to promote public health, prevent unnecessary duplication.
  • 5. What is ICH ? •The complete name of ICH is the "International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use". •The purpose is to make recommendations on ways to achieve greater harmonization in the interpretation and application of technical guidelines and requirements for product registration in order to reduce or prevent the need to duplicate the testing carried out during the research and development of new medicines. • This unique project brings together the participants in the three regions to discuss scientific and technical aspects of product registration
  • 6. The focus of the is to provide a common format for the preparation of a well structured submission according to the modular framework described in the ICH guidelines of the Common Technical Document for Registration for Human Use (ICH Topic M4). The CTD guidance indicates where and how available information is to be presented. The CTD is not intended to indicate what studies are actually required (Authorities can ask for specific types of data).
  • 7. CTD is a joint effort of 3 Regulatory Agencies-  European Medicines Agency (EMEA, Europe)  Food and Drug Administration (FDA, USA) and  Ministry of Health, Labour and Welfare (MHLW, Japan). CTD is maintained by ICH through Expert working group (EWG). It has been adopted by several other countries including Canada and Switzerland
  • 8. These different steps are called STATUS of that Guideline- STATUS FUNCTIONALITY STEP 1 Development of Consensus STEP 2 Text released for Consultation STEP 3 Consultation outside ICH STEP 4 ICH Guidelines Finalized STEP 5 Implementation
  • 9. Avoid generating and compiling different registration dossiers Common format will significantly reduce the time and resources Facilitates simultaneous submission in three regions Facilitates exchange of information among regulatory authorities Faster availability of new medicines.
  • 10. The CTD is organized into FIVE modules:  Module 1: Regional Administrative Information.  Module 2: Introduction, Quality Overall Summary, Nonclinical Overview, Clinical Overview, Nonclinical Written and Tabulated Summaries, Clinical Summary  Module 3: Quality  Module 4: Nonclinical Study Reports  Module 5: Clinical Study Reports.
  • 11. The Common Technical Document is organized into five modules. Module 1 is region specific and modules 2, 3, 4 and 5 are intended to be common for all regions.
  • 12. 1. ADMINISTRATIVE 1. FDA form 356h 2. Cover letter 3. Patent information 4. Department Certification 5. Field copy certification 6. User Fee cover sheet 7. Financial disclosure information
  • 13. 1. CTD Table of content 2. CTD Introduction 3. Quality Control Summary 4. Non-Clinical Overview 5. Clinical Overview 6. Non Clinical Summary 7. Clinical Summary
  • 20. • The eCTD is the electronic equivalent to the CTD. Why electronic? –Improve the submission and review process –Increase accuracy of the submission –Decrease total costs •This specification has been developed by the ICH M2 Expert Working group and maintained by the eCTD Implementation Working group in accordance with the ICH Process.
  • 21. eCTD Changes •XML based eCTD backbone replaces PDF Tables of Content (index xml file). The purpose of this file is two‐fold: • Manage meta‐data for the entire submission •Constitute a comprehensive table of contents and provide corresponding navigation aid •Increase document granularity in accordance with ICH eCTD agreements. • Life Cycle Management: –Composed at least of an initial submission –Incremental updates –Only what was changed needs to be re‐submitted
  • 22. eCTD Specification v 3.2 eCTD is a message specification for the transfer of files and metadata from industry to regulatory. The eCTD Specification version 3.2 describes many optional folders and file names.
  • 24. eCTD SUBMISSION CHECKLIST-  eCTD Software  Software training and support from the supplier  Compiling and eCTD  eCTD hyper linking  QC of eCTD  Submit eCTD on CD/DVD or Use electronic gateway
  • 25. eCTD Implementation- eCTD is implemented in 2009 •ICH‐eCTD is an internationally driven standard designed to reduce cost in the administration, assessment and archiving of applications for marketing authorization of medicinal products for human use, to reduce the use of paper and streamline the assessment process making the system more efficient. •Unlike CTD the eCTD is not mandatory in Europe (highly recommended). •NCAs are progressively adapting their infrastructure, processes and legislation to be able to receive and handle paperless applications for marketing authorization by 2009.
  • 26. Benefits of eCTD • Improved handling and archiving of submissions • Better information management Support of Life Cycle Management • Immediate Access to complete and up‐to‐date information •Search functionality for assessors and increased tracking ability • Facilitated evaluation and better visibility of the process •Reduced workload and reuse of information for assessment reports • Controlled communication with external experts • Better use of resources • Simplified business process • Better communication with industry
  • 27. SFDA Plan for Submission- • Application form should be submitted online •SFDA will require the product file in both CTD(Hardcopy) and eCTD (Softcopy) format •Product file registration should follow the current requirements, but in CTD format
  • 28. SFDA Prospective for Submission • Learning process • Step by step implementation • Review of the business process • Build a workflow system • Pilot phase • Smooth transition